(V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB))
NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF- kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF- kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. Stimulates promoter activity in the presence of p49- and p50-NF-kappa-B. Neither associates with DNA nor with p65-NF-kappa-B (By similarity).
Ta, Schwensen, Liuwantara, Huso, Watnick, Rangan: "Constitutive renal Rel/nuclear factor-κB expression in Lewis polycystic kidney disease rats." in: World journal of nephrology, Vol. 5, Issue 4, pp. 339-57, (2016) (PubMed).
Pyz, Naidenko, Miyake, Yamamura, Berberich, Cardell, Kronenberg, Herrmann: "The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 176, Issue 12, pp. 7447-55, (2006) (PubMed).
Kaetzel: "The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces." in: Immunological reviews, Vol. 206, pp. 83-99, (2005) (PubMed).
Marienfeld, Berberich-Siebelt, Berberich, Denk, Serfling, Neumann: "Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-kappaB control." in: Oncogene, Vol. 20, Issue 56, pp. 8142-7, (2002) (PubMed).